NAPA and cancer: Based on structural similarity with kinase inhibitors, we additionally performed a kinome screen to profile binding of APA and its acetylated product NAPA with respect to > 300 kinases, and identified differential binding to Aurora Kinase A (AURKA) which is a known drug target in cancer.